Verastem Operating Margin vs Free Cash Flow per Share Analysis
VSTM Stock | USD 9.84 0.39 3.81% |
Verastem financial indicator trend analysis is much more than just breaking down Verastem prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Verastem is a good investment. Please check the relationship between Verastem Operating Profit Margin and its Free Cash Flow Per Share accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verastem. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.
Operating Profit Margin vs Free Cash Flow Per Share
Operating Margin vs Free Cash Flow per Share Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Verastem Operating Margin account and Free Cash Flow per Share. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Verastem's Operating Margin and Free Cash Flow per Share is -0.57. Overlapping area represents the amount of variation of Operating Margin that can explain the historical movement of Free Cash Flow per Share in the same time period over historical financial statements of Verastem, assuming nothing else is changed. The correlation between historical values of Verastem's Operating Margin and Free Cash Flow per Share is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Margin of Verastem are associated (or correlated) with its Free Cash Flow per Share. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow per Share has no effect on the direction of Operating Margin i.e., Verastem's Operating Margin and Free Cash Flow per Share go up and down completely randomly.
Correlation Coefficient | -0.57 |
Relationship Direction | Negative |
Relationship Strength | Very Weak |
Operating Profit Margin
Free Cash Flow Per Share
The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.Most indicators from Verastem's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Verastem current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verastem. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.At this time, Verastem's Selling General Administrative is very stable compared to the past year. As of the 19th of April 2024, Issuance Of Capital Stock is likely to grow to about 125.5 M, while Sales General And Administrative To Revenue is likely to drop 2.31.
Verastem fundamental ratios Correlations
Click cells to compare fundamentals
Verastem Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Verastem fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 145.0M | 154.3M | 108.7M | 95.1M | 149.7M | 125.4M | |
Other Current Liab | 450K | 14.7M | 15.6M | 15.0M | 17.9M | 9.3M | |
Total Current Liabilities | 29.9M | 17.1M | 18.6M | 21.7M | 26.4M | 16.6M | |
Total Stockholder Equity | 7.2M | 115.3M | 87.6M | 47.4M | 78.5M | 77.0M | |
Accounts Payable | 9.7M | 1.9M | 2.3M | 4.9M | 7.2M | 5.0M | |
Cash | 43.5M | 67.8M | 100.3M | 74.9M | 78.8M | 63.4M | |
Common Stock Shares Outstanding | 6.2M | 12.8M | 14.5M | 16.1M | 22.1M | 23.2M | |
Other Current Assets | 3.8M | 3.5M | 105.7M | 4.9M | 5.6M | 10.2M | |
Total Liab | 137.9M | 39.1M | 21.1M | 47.7M | 71.2M | 48.4M | |
Common Stock | 7K | 8K | 17K | 19K | 20K | 2.9K | |
Property Plant Equipment | 947K | 3.1M | 210K | 92K | 105.8K | 100.5K | |
Property Plant And Equipment Net | 4.0M | 3.1M | 210K | 1.9M | 1.2M | 1.8M | |
Net Debt | 64.0M | (45.2M) | (98.0M) | (47.9M) | (37.3M) | (39.1M) | |
Retained Earnings | (524.8M) | (592.5M) | (663.7M) | (737.5M) | (824.9M) | (783.6M) | |
Non Current Assets Total | 60.1M | 9.4M | 2.9M | 2.2M | 6.0M | 11.4M | |
Non Currrent Assets Other | 36.1M | 274K | 2.5M | 58K | 4.6M | 4.2M | |
Other Assets | 36.1M | 9.0M | 410K | 299K | 343.9K | 326.7K | |
Cash And Short Term Investments | 75.5M | 141.2M | 100.3M | 87.9M | 138.1M | 115.8M | |
Common Stock Total Equity | 8K | 17K | 19K | 20K | 23K | 24.2K | |
Short Term Investments | 32.0M | 73.4M | 79.0M | 13.0M | 59.2M | 61.7M | |
Liabilities And Stockholders Equity | 145.0M | 154.3M | 108.7M | 95.1M | 149.7M | 134.7M | |
Non Current Liabilities Total | 108.0M | 22.0M | 2.5M | 26.0M | 44.8M | 34.2M | |
Other Stockholder Equity | 531.9M | 707.7M | 751.2M | 784.9M | 882.2M | 470.0M | |
Property Plant And Equipment Gross | 4.0M | 416K | 4.2M | 3.4M | 2.8M | 2.2M | |
Total Current Assets | 85.0M | 144.9M | 105.7M | 92.9M | 143.7M | 119.1M | |
Accumulated Other Comprehensive Income | 14K | 53K | 34K | 13K | 15.0K | 15.7K | |
Net Tangible Assets | (12.8M) | 115.3M | 87.6M | 47.4M | 42.7M | 63.3M | |
Long Term Debt | 103.6M | 19.1M | 249K | 24.5M | 40.1M | 29.1M | |
Net Receivables | 2.5M | 239K | 516K | 31K | 42K | 39.9K | |
Retained Earnings Total Equity | (524.8M) | (592.5M) | (663.7M) | (737.5M) | (663.8M) | (630.6M) | |
Capital Surpluse | 531.9M | 707.7M | 751.2M | 784.9M | 902.6M | 481.7M | |
Non Current Liabilities Other | 4.4M | 2.9M | 2.3M | 1.5M | 1.7M | 1.4M | |
Short Long Term Debt Total | 107.5M | 22.5M | 2.3M | 27.1M | 41.6M | 38.4M | |
Long Term Debt Total | 103.6M | 19.1M | 249K | 24.5M | 22.1M | 36.9M | |
Net Invested Capital | 110.8M | 134.3M | 87.8M | 72.2M | 97.5M | 93.7M | |
Net Working Capital | 55.1M | 127.8M | 87.2M | 71.2M | 117.3M | 85.2M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Verastem is a strong investment it is important to analyze Verastem's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Verastem's future performance. For an informed investment choice regarding Verastem Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verastem. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for Verastem Stock analysis
When running Verastem's price analysis, check to measure Verastem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verastem is operating at the current time. Most of Verastem's value examination focuses on studying past and present price action to predict the probability of Verastem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verastem's price. Additionally, you may evaluate how the addition of Verastem to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
Is Verastem's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verastem. If investors know Verastem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verastem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.96) | Quarterly Revenue Growth (1.00) | Return On Assets (0.47) | Return On Equity (1.39) |
The market value of Verastem is measured differently than its book value, which is the value of Verastem that is recorded on the company's balance sheet. Investors also form their own opinion of Verastem's value that differs from its market value or its book value, called intrinsic value, which is Verastem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verastem's market value can be influenced by many factors that don't directly affect Verastem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verastem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verastem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verastem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.